Big Drug Companies Should Secede From The Pharmaceutical Research And Manufacturers Of America – Forbes


Forbes
Big Drug Companies Should Secede From The Pharmaceutical Research And Manufacturers Of America
Forbes
When Martin Shkreli, then the CEO of Turing Pharmaceuticals, infamously raised the price of the rare disease drug, Daraprim, from $13.50 to $750/pill, big drug companies quickly scrambled to disassociate themselves from the person who was being called …

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd